Demographic, Survivorship, and Health Characteristics
Demographic, treatment exposures, and chronic health conditions among
survivors with short and typical sleep duration are summarized in Table
3. Survivors were 51.8% female, predominately non-Hispanic white
(84.1%), an average of 34 years of age, and 26 years from their cancer
diagnosis. Leukemia (41.4%), non-central nervous system solid tumors
(23.4%), and Hodgkin lymphoma (13.2%) were the most common diagnoses
among participants. Grade 2 or higher cardiac (40.8%), endocrine
(50.0%), neurologic (31.0%), gastrointestinal/hepatic (31.1 %),
musculoskeletal (30.1%) and pulmonary (26.3%) conditions were
prevalent in the sample. Grade 2 or higher renal conditions (9.9%),
anxiety (6.7%) and depression (7.6%) were less common among survivors.
Several health outcomes were more prevalent among short sleepers
(< 7 hours) compared to those with typical sleep duration (7
to 9 hours) such as: anxiety 10.6% vs. 3.4% (p<0.0001),
depression 10.3% vs. 5.2% (p=0.0100), endocrine 55.8% vs. 45.5%
(p=0.0022), pulmonary 30.3% vs. 23.0% (p=0.0147), and
gastrointestinal/hepatic conditions 37.0% vs. 26.3% (p=0.0006) (Table
3).